Science News
from research organizations

Public funding essential for advances in biomedical research

Cuts in National Institutes of Health budget could impact innovation

Date:
March 30, 2017
Source:
Harvard Business School
Summary:
Article shows that publicly-funded research creates knowledge that links to private companies' efforts to develop drugs, medical devices, and other patented biomedical products.
Share:
FULL STORY

In a study of 365,000 NIH grants — nearly every NIH grant awarded for 27 years — researchers found that 31 percent produce articles that are later cited by patents in the biomedical sector.
Credit: Christine Daniloff/MIT

In the budget President Trump recently submitted to Congress, he asked for a reduction in the 2018 funding of the U.S. National Institutes of Health (NIH) of almost 20 percent -- or $6 billion.

That could have consequences for those suffering from a variety of illnesses and conditions and for biomedical innovation, based on results from an article to be published in Science on Friday, March 31, 2017 and coauthored by Assistant Professor Danielle Li of Harvard Business School, Professor Pierre Azoulay of MIT Sloan School of Management and the National Bureau of Economic Research (NBER), and Associate Professor Bhaven N. Sampat of Columbia University's Mailman School of Public Health and NBER.

"Our article, 'The Applied Value of Public Investments in Biomedical Research,' shows that publicly-funded research creates knowledge that links to private companies' efforts to develop drugs, medical devices, and other patented biomedical products," says Harvard's Li. "We find that 30 percent of NIH-funded grants produce research that is cited by a private-sector patent."

NIH, the world's largest single funder of research in the life sciences, provides support for one-third of biomedical R&D in the United States, as well as the majority of funding for so-called "basic" or broad-based biomedical research. Using data on life science patents (including drugs, devices, and other medical technologies), Li, Azoulay, and Sampat analyze the output of research grants awarded by NIH over a 27-year period and provide a method for large-scale accounting of linkages between these public research investments and their commercial applications. Recognizing that some patents are more valuable than others, they also examine linkages between NIH grants and patents associated with marketed drugs.

"We find that about 10 percent of NIH grants generate a patent directly -- an easier-to-grasp metric that policy makers often focus on to capture the near-term economic returns to public funding of biomedical R&D," say the authors. "According to our research, however, a much larger number of NIH grants -- about 30 percent of them -- generate articles that are subsequently cited by commercial patents. Focusing solely on the direct patent output of NIH funding may dramatically understate its importance for producing research that informs commercial innovation."

In addition, Li, Azoulay, and Sampat find that grants for "basic" science are almost just as likely to be cited by patents as grants for more "applied" work -- which may be surprising to those who question its practical value.


Story Source:

Materials provided by Harvard Business School. Note: Content may be edited for style and length.


Cite This Page:

Harvard Business School. "Public funding essential for advances in biomedical research: Cuts in National Institutes of Health budget could impact innovation." ScienceDaily. ScienceDaily, 30 March 2017. <www.sciencedaily.com/releases/2017/03/170330142303.htm>.
Harvard Business School. (2017, March 30). Public funding essential for advances in biomedical research: Cuts in National Institutes of Health budget could impact innovation. ScienceDaily. Retrieved May 26, 2017 from www.sciencedaily.com/releases/2017/03/170330142303.htm
Harvard Business School. "Public funding essential for advances in biomedical research: Cuts in National Institutes of Health budget could impact innovation." ScienceDaily. www.sciencedaily.com/releases/2017/03/170330142303.htm (accessed May 26, 2017).

MORE COVERAGE

RELATED STORIES